Alpharadin™ (Radium-223 Chloride) Safety and Dosimetry With HRPC That Has Metastasized to the Skeleton
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate the safety, biodistribution, radiation dosimetry
and pharmacokinetics of three intravenous escalating dose levels of Xofigo (Alpharadin).